Observational studyJournal of general internal medicine2025
Virtual Reality as RESPITE: Relief Exploration for Sickle Pain Through Interventions Using Technology Engagement: A Hospital-Based Observational Study.
Observational study in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Barriers and Facilitators to Equitable Implementation of Long-Acting Injectable PrEP for Racial, Gender and Sexual Minority Populations in NYC: The EquiPrEP Study.AIDS and behavior · 2026Article
- Letter to the Editor: Virtual Reality as RESPITE: Relief Exploration for Sickle Pain Through Interventions Using Technology Engagement: A Hospital‑Based Observational Study.Journal of general internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe opioid epidemic, side effects from acute and chronic opioid use, and low utilization of preventive medications for sickle cell disease (SCD) necessitate the development of novel strategies to manage painful vaso-occlusive episodes. Virtual reality (VR) has shown promise for pediatric patients with SCD; however, interest in VR among adults with SCD is under examined. Ensuring equitable access to VR-based interventions requires understanding of factors that determine patients' interest in VR.
objectiveTo assess interest, preferences, and predictors regarding interest in VR-based interventions to manage SCD-related pain.
designCross-sectional, observational, single-site study conducted between 2023 and 2024.
participantsHospitalized, English-speaking, had a SCD diagnosis, and aged ≥ 18 years. MAIN MEASURES: The primary outcome was participants' interest in using VR. General health literacy (HL) and electronic health literacy (eHL) were assessed using Brief Health Literacy Screen and eHealth Literacy Scale, respectively, to compare differences between participants interested versus uninterested in using VR to manage pain. Participants also indicated preferred gaming genres and barriers to VR use. KEY
resultsAmong 40 participants (80% response rate), most self-identified as Black (95%) and male (58%); 43% had low HL; and 13% had low eHL. Most (85%) participants indicated interest in using VR for pain management (n = 34/40). Participants uninterested in using VR were more likely to have low HL (100% vs. 33%; p = 0.002) and low eHL (67% vs. 3%; p < 0.001) than participants interested in VR. Skill development (82%; e.g., learning how to rock-climb) and adventure (82%) genres were most preferred among interested participants. Cost (65%) and access to VR devices (35%) were cited as notable barriers.
conclusionsThe present study identifies that people with SCD regard VR as a promising intervention for pain management. Future studies include designing equitably accessible VR interventions and assessing efficacy, paying attention to factors like electronic and general health literacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.